EBC-170066
Compound libraries
Products
EBC main page
Search
Dyes
Impurities
Chemical probes
Contacts us
Pfizer reference compounds
Services
© 2026 Copyright Enamine
Back
Product details:
CAS
59-92-7
Purity
95%
Levodopa is a prodrug of dopamine that is administered to patients with Parkinson's due to its ability to cross the blood-brain barrier. Levodopa can be metabolised to dopamine on either side of the blood-brain barrier and so it is generally administered with a dopa decarboxylase inhibitor like carbidopa to prevent metabolism until after it has crossed the blood-brain barrier.
Properties
Name
Levodopa
Smiles
N[C@@H](CC=1C=CC(O)=C(O)C1)C(=O)O
Targets
Please log in to see this information
Impurity
SDS
(-)-3-(3,4-dihydroxylphenyl)-L-alanine | (2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid | (S)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid | (S)-3,4-dihydroxyphenylalanine | 3,4-dihydroxy-L-phenylalanine | 3,4-dihydroxyphenyl-L-alanine | 3,4-dihydroxyphenylalanine | 3-(3,4-dihydroxyphenyl)-L-alanine | 3-hydroxy-L-tyrosine | 3-hydroxytyrosine | L-3,4-dihydroxylphenylalanine | L-3,4-dihydroxyphenylalanine | L-3-(3,4-dihydroxyphenyl)-alanine | L-DOPA | L-dihydroxyphenylalanine | L-dopamine | L‐dopa | dihydroxyphenylalanine | dopa | dopamine | levodopa | madopar
No data available
The compound has purity validated by NMR and/or LCMS methods.
1 mg
$19
2 mg
$19
5 mg
$19
10 mg
$19
15 mg
$19
20 mg
$19
25 mg
$19
30 mg
$19
35 mg
$19
40 mg
$19
45 mg
$19
50 mg
$19
75 mg
$19
100 mg
$POA
Quantity
1
Total amount
$ 19
(-)-3-(3,4-dihydroxylphenyl)-L-alanine | (2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid | (S)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid | (S)-3,4-dihydroxyphenylalanine | 3,4-dihydroxy-L-phenylalanine | 3,4-dihydroxyphenyl-L-alanine | 3,4-dihydroxyphenylalanine | 3-(3,4-dihydroxyphenyl)-L-alanine | 3-hydroxy-L-tyrosine | 3-hydroxytyrosine | L-3,4-dihydroxylphenylalanine | L-3,4-dihydroxyphenylalanine | L-3-(3,4-dihydroxyphenyl)-alanine | L-DOPA | L-dihydroxyphenylalanine | L-dopamine | L‐dopa | dihydroxyphenylalanine | dopa | dopamine | levodopa | madopar
No data available
The compound has purity validated by NMR and/or LCMS methods.
Target activity features
It should be emphasized that the product may be active against a larger number of targets than shown on the card. The information represented here refers to the targets with the largest value of pX or the targets with ΔpX less than 1.5 from the largest pX value.